BBLN

In a report released on November 10, David Larsen from BTIG maintained a Buy rating on Babylon (BBLN - Research Report), with a price target of $4.00. The company's shares closed last Friday at $0.53.According to TipRanks, Larsen is an analyst with an average return of -12.1% and a 31.22% success rate. Larsen covers the Technology sector, focusing on stocks such as Signify Health, Omnicell, and Health Catalyst.Currently, the analyst consensus on Babylon is a Strong Buy with an average price target of $2.90, representing a 447.17% upside. In a report released on November 11, Canaccord Genuity also maintained a Buy rating on the stock with a $2.00 price target.
https://www.tipranks.com/news/blurbs/babylon-bbln-gets-a-buy-from-btig?utm_source=advfn.com&utm_medium=referral